Rational Vaccines
Blood & Organ Banks · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
8 Cabot Rd Ste 3800, Woburn, Massachuset...Phone Number
(781) 305-3600Website
www.rationalvaccines.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
2
2
2
About Rational Vaccines
Rational Vaccines is an investigational-stage biotech firm focused on developing live-attenuated vaccines to combat herpes simplex virus infections. The company aims to revolutionize the treatment, prevention, and diagnosis of herpes and related diseases globally, utilizing proprietary technology to create immunotherapeutic and prophylactic vaccine candidates. Targeting both HSV-1 and HSV-2, Rational Vaccines seeks to improve the lives of those affected and reduce the virus's spread. Their vision includes a future free of herpes, addressing a significant global health challenge.Explore more
Rational Vaccines Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rational Vaccines your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Rational Vaccines, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Rational Vaccines has new funding data
Congratulate Masked Content for being promoted to Masked Content at Rational Vaccines
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Rational Vaccines is spiking on competitors!
Product Launch: Get notified when Rational Vaccines launches new products
Check if Rational Vaccines has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Rational Vaccines recently announced quarterly report
Click to see if Rational Vaccines had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Rational Vaccines
Compare insights from companies similar to Rational Vaccines, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Rational Vaccines is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Rational Vaccines is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Rational Vaccines.
Rational Vaccines financials insights
Gather financial insights about Rational Vaccines, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Private Equity
$8.2M
Rational Vaccines Tech Stack
A closer look at the technologies used by Rational Vaccines
See more technologies
Most Recent Scoops
Funding
Project
Award, Spending/Investment
Funding
Project
Award, Spending/Investment
New Hire
Executive Move
New Hire
New Hire
Executive Move
Rational Vaccines News & Media
Rational Vaccines Announces a Clinical Trial to Determine Baseline Characteristics of Patients Diagnosed With Recurrent Symptomatic Herpes Simplex Type 2 (HSV-2) Virus
Study to be conducted at two leading research institutions in the U.K. Results will inform protocol design of Phase 1/2 clinical trial of Company's lead HSV-2 therapeutic vaccine candidate WOBURN, Mass. and OXFORD, England, Aug. 15, 2022 /PRNewswire/ -- Rational Vaccines, a company...Rational Vaccines Herpes Simplex Type 2 (HSV-2) Therapeutic Vaccine Candidate Demonstrates Efficacy in a Therapeutic Animal Study
NIH-funded study shows RVX201 exhibits robust protection against recurrent HSV-2 disease in guinea pig model WOBURN, Mass. and OXFORD, England, July 8, 2022 /PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the...Rational Vaccines' Herpes Vaccine RVx1001 Shows Promise as a Viral Vector Platform to Express Malaria Proteins and Confer Protection against Malaria Infection in Mice According to a Recent Study Published in Vaccines
Research shows company's novel HSV-1-derived viral vaccine has significant potential to produce vaccines to combat infectious diseases including malaria. WOBURN, Mass. and OXFORD, England, May 10, 2022 /PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment...Rational Vaccines' RVX1001 Vaccine Candidate Protects Against HSV Ocular Infection in vivo
WOBURN, Mass. and OXFORD, England, Dec. 28, 2021 /PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes simplex viruses (HSV) to eradicate all forms of herpectic disease, today announced preclinical research suggesting that the...
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rational Vaccines
Sign Up For FreeTo access detailed company insights
Rational Vaccines is an investigational-stage biotech firm focused on developing live-attenuated vaccines to combat herpes simplex virus infections. The company aims to revolutionize the treatment, prevention, and diagnosis of herpes and related diseases globally, utilizing proprietary technology to create immunotherapeutic and prophylactic vaccine... Read More
